Medicare payments for dialysis, cost the US government $5 billion a year. The global market for chronic dialysis services is worth approximately $43 billion and the US market is the largest in the ...

The FDA has lifted an alert preventing the import of Sweden-based Gambro’s Phoenix and Prismaflex renal care machines into the United States following re-inspection of the company’s manufacturing ...

Stockholm, Sweden - Gambro Renal Products, a division of Gambro AB, announced it has received 501(K) approval to market its high-flux, steam-sterilized pediatric dialyzer in the US. The Polyflux 6H ...

Gambro AB, the world’s largest dialysis products producer, may lose an important supply agreement with El Segundo-based dialysis service provider DaVita Inc. because of a U.S. ban on imports of Gambro ...

Gambro AB will continue building a new artificial kidney plant in Opelika, Ala., despite contract difficulties with one of its major customers. DaVita Inc. of El Segundo, Calif., notified Gambro it ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/kdvt7p/gambro_medical) has announced the addition of the "Gambro Medical ...